Skip to main content
Top
Published in: Rheumatology International 6/2012

Open Access 01-06-2012 | Original Article

The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan

Authors: Toshikatsu Okumura, Satoshi Tanno, Masumi Ohhira, Tsukasa Nozu

Published in: Rheumatology International | Issue 6/2012

Login to get access

Abstract

We analyzed the rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome, both characterized as seronegative inflammatory arthritis in elderly, in an outpatient unit where primary care physicians are working in Japan to better understand the epidemiological characteristics of the diseases in Japan. Consecutive outpatients who newly visited at Department of General Medicine, Asahikawa Medical University Hospital, Japan, between April 2004 and March 2010 were analyzed. Each parameter such as age, sex, diagnosis, and biochemical examination was investigated. During the 6 years, 10 or 3 patients were diagnosed as PMR or RS3PE syndrome, respectively. The patients with PMR were 7 women and 3 men, and the average age at diagnosis was 69. Out of all patients aged over 50 (n = 3,347), the rate of PMR was 0.22% in men or 0.36% in women, respectively. On the other hand, RS3PE syndrome was diagnosed in 3 men (76, 76, and 81 years old). The rate of patients with RS3PE syndrome was 0.09% among outpatients aged over 50 indicating that the rate of PMR in an outpatient clinic in Japan is not far from previous findings reported from western countries. When compared with PMR, the rate of RS3PE syndrome was approximately one-third, providing for the first time the rate of RS3PE syndrome when compared with PMR. These epidemilogical data might help us pick up the diseases in primary care setting in Japan.
Literature
2.
go back to reference Doran MF, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2002) Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 29:1694–1697PubMed Doran MF, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2002) Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 29:1694–1697PubMed
3.
go back to reference Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK (2001) Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 40:1238–1242CrossRef Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK (2001) Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 40:1238–1242CrossRef
4.
go back to reference Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098PubMedCrossRef Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098PubMedCrossRef
5.
go back to reference Vanhoof J, Declerck K, Geusens P (2002) Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 61:453–455PubMedCrossRef Vanhoof J, Declerck K, Geusens P (2002) Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 61:453–455PubMedCrossRef
6.
go back to reference Chakravarty K, Elgabani SH, Scott DG, Merry P (1994) A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 33:152–156PubMedCrossRef Chakravarty K, Elgabani SH, Scott DG, Merry P (1994) A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 33:152–156PubMedCrossRef
7.
go back to reference Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum 53:395–403PubMedCrossRef Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum 53:395–403PubMedCrossRef
8.
go back to reference Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al (2008) National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35PubMedCrossRef Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al (2008) National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35PubMedCrossRef
9.
go back to reference Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG (1995) Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum 38:369–373PubMedCrossRef Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG (1995) Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum 38:369–373PubMedCrossRef
10.
go back to reference Bernatsky S, Joseph L, Pineau CA, Belisle P, Lix L, Banerjee D, Clarke AE (2009) Polymyalgia rheumatica prevalence in a population-based sample. Arthritis Rheum 61:1264–1267PubMedCrossRef Bernatsky S, Joseph L, Pineau CA, Belisle P, Lix L, Banerjee D, Clarke AE (2009) Polymyalgia rheumatica prevalence in a population-based sample. Arthritis Rheum 61:1264–1267PubMedCrossRef
11.
go back to reference Nobunaga M, Yoshioka K, Yasuda M, Shingu M (1989) Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 28:452–456 Nobunaga M, Yoshioka K, Yasuda M, Shingu M (1989) Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 28:452–456
12.
go back to reference Yanai H, Yoshida H, Tada N (2009) Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica. Clin Interv Aging 4:391–395PubMedCrossRef Yanai H, Yoshida H, Tada N (2009) Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica. Clin Interv Aging 4:391–395PubMedCrossRef
13.
go back to reference Aoki Y, Iwamoto M, Minota S (2009) Clinical features in patients with polymyalgia rheumatica. Jpn J Clin Immunol 32:274–278 (In Japanese)CrossRef Aoki Y, Iwamoto M, Minota S (2009) Clinical features in patients with polymyalgia rheumatica. Jpn J Clin Immunol 32:274–278 (In Japanese)CrossRef
14.
go back to reference Shintani S, Shiigai T, Matsui Y (2002) Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients. Clin Neurol Neurosurg 104:20–29PubMedCrossRef Shintani S, Shiigai T, Matsui Y (2002) Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients. Clin Neurol Neurosurg 104:20–29PubMedCrossRef
15.
go back to reference Mori S, Koga Y, Ito K (2007) Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging. Mol Rheumatol 17:369–375CrossRef Mori S, Koga Y, Ito K (2007) Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging. Mol Rheumatol 17:369–375CrossRef
16.
go back to reference Olivieri I, Salvarani C, Cantini F (2000) RS3PE syndrome: an overview. Clin Exp Rheumatol 18(Suppl 20):S53–S55PubMed Olivieri I, Salvarani C, Cantini F (2000) RS3PE syndrome: an overview. Clin Exp Rheumatol 18(Suppl 20):S53–S55PubMed
17.
go back to reference McCarty DJ, O’Duffy JD, Pearson L, Hunter JB (1985) Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 254:2763–2767PubMedCrossRef McCarty DJ, O’Duffy JD, Pearson L, Hunter JB (1985) Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 254:2763–2767PubMedCrossRef
18.
go back to reference Takahashi K, Fujinaga H, Kobayashi M, Naito T, Iida H (2002) Aoki S (2002) Seven cases of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome. Nippon Ronen Igakkai Zasshi 39:643–647 (In Japanese)PubMedCrossRef Takahashi K, Fujinaga H, Kobayashi M, Naito T, Iida H (2002) Aoki S (2002) Seven cases of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome. Nippon Ronen Igakkai Zasshi 39:643–647 (In Japanese)PubMedCrossRef
19.
go back to reference Oide T, Ohara S, Oguchi K, Maruyama M, Yazawa M, Inoue K et al (2004) Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients. Clin Exp Rheumatol 22:91–98PubMed Oide T, Ohara S, Oguchi K, Maruyama M, Yazawa M, Inoue K et al (2004) Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients. Clin Exp Rheumatol 22:91–98PubMed
20.
go back to reference Shimojima Y, Matsuda M, Ishii W, Gono T, Ikeda S (2008) Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis. Clin Exp Rheumatol 26:1079–1082PubMed Shimojima Y, Matsuda M, Ishii W, Gono T, Ikeda S (2008) Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis. Clin Exp Rheumatol 26:1079–1082PubMed
21.
go back to reference Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M et al (2005) RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 64:1653–1655PubMedCrossRef Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M et al (2005) RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 64:1653–1655PubMedCrossRef
22.
go back to reference Bahlas S, Ramos-Remus C, Davis P (2000) Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians. Clin Rheumatol 19:278–280PubMedCrossRef Bahlas S, Ramos-Remus C, Davis P (2000) Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians. Clin Rheumatol 19:278–280PubMedCrossRef
23.
go back to reference Tanno S, Ohhira M, Tsuchiya Y, Takeuchi T, Tanno S, Okumura T (2009) Frequent early discontinuation of SSRI prescribed by primary care physicians in young males in Japan. Intern Med 48:1263–1266PubMedCrossRef Tanno S, Ohhira M, Tsuchiya Y, Takeuchi T, Tanno S, Okumura T (2009) Frequent early discontinuation of SSRI prescribed by primary care physicians in young males in Japan. Intern Med 48:1263–1266PubMedCrossRef
24.
go back to reference Okumura T, Tanno S, Ohhira M, Tanno S (2010) Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 45:187–194PubMedCrossRef Okumura T, Tanno S, Ohhira M, Tanno S (2010) Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 45:187–194PubMedCrossRef
25.
go back to reference Dasgupta B, Matteson EL, Maradit-Kremers H (2007) Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol 25(Suppl 47):130–136PubMed Dasgupta B, Matteson EL, Maradit-Kremers H (2007) Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol 25(Suppl 47):130–136PubMed
26.
go back to reference Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S et al (2005) A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 64:626–629PubMedCrossRef Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S et al (2005) A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 64:626–629PubMedCrossRef
27.
go back to reference Bucaloiu ID, Olenginski TP, Harrington TM (2007) Remitting seronegative symmetrical synovitis with pitting edema syndrome in a rural tertiary care practice: a retrospective analysis. Mayo Clin Proc 82:1510–1515PubMedCrossRef Bucaloiu ID, Olenginski TP, Harrington TM (2007) Remitting seronegative symmetrical synovitis with pitting edema syndrome in a rural tertiary care practice: a retrospective analysis. Mayo Clin Proc 82:1510–1515PubMedCrossRef
28.
go back to reference Cantini F, Salvarani C, Olivieri I (1999) Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol 17:741–744PubMed Cantini F, Salvarani C, Olivieri I (1999) Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol 17:741–744PubMed
29.
go back to reference Paira S, Graf C, Roverano S, Rossini J (2002) Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol 21:146–149PubMedCrossRef Paira S, Graf C, Roverano S, Rossini J (2002) Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol 21:146–149PubMedCrossRef
30.
go back to reference Bahlas S, Ramon-Remus C, Davis P (1998) Clinical outcome of 149 patients with polymyalgia ehumatica and giant cell arteritis. J Rheumatol 25:99–104PubMed Bahlas S, Ramon-Remus C, Davis P (1998) Clinical outcome of 149 patients with polymyalgia ehumatica and giant cell arteritis. J Rheumatol 25:99–104PubMed
31.
go back to reference Salvarani C, Cantani F, Macchioni P, Olivieri I, Niccoli L, Padula A et al (1998) Distal musculoskeltal manifestations in polymyalgia rheumatica. Artheritis Rheum 41:1221–1226CrossRef Salvarani C, Cantani F, Macchioni P, Olivieri I, Niccoli L, Padula A et al (1998) Distal musculoskeltal manifestations in polymyalgia rheumatica. Artheritis Rheum 41:1221–1226CrossRef
32.
go back to reference Huchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B et al (2007) Clinical outcomes, quality of life, and diagnistic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum 57:803–809CrossRef Huchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B et al (2007) Clinical outcomes, quality of life, and diagnistic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum 57:803–809CrossRef
33.
go back to reference Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A et al (2004) Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 58:193–199PubMedCrossRef Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A et al (2004) Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 58:193–199PubMedCrossRef
34.
go back to reference Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K et al (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309–313PubMedCrossRef Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K et al (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309–313PubMedCrossRef
35.
go back to reference Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA et al (2004) Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 10:5137–5144PubMedCrossRef Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA et al (2004) Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 10:5137–5144PubMedCrossRef
36.
go back to reference Jennbacken K, Vallbo C, Wang W, Damber JE (2005) Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 65:110–116PubMedCrossRef Jennbacken K, Vallbo C, Wang W, Damber JE (2005) Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 65:110–116PubMedCrossRef
37.
go back to reference Tuomela J, Valta M, Seppänen J, Tarkkonen K, Väänänen HK, Härkönen P (2009) Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer 9:362PubMedCrossRef Tuomela J, Valta M, Seppänen J, Tarkkonen K, Väänänen HK, Härkönen P (2009) Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer 9:362PubMedCrossRef
Metadata
Title
The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan
Authors
Toshikatsu Okumura
Satoshi Tanno
Masumi Ohhira
Tsukasa Nozu
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1849-3

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.